New marijuana & psychedelics bills in Congress; MO cannabis & psilocybin legislation; GOP lawmaker on banking access; 4,000+ marijuana studies in 2025
Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day.
Your support makes Marijuana Moment possible…
Your good deed for the day: donate to an independent publisher like Marijuana Moment and ensure that as many voters as possible have access to the most in-depth cannabis reporting out there.
Support our work at https://www.patreon.com/marijuanamoment
/ TOP THINGS TO KNOW
Congressional Cannabis Caucus Co-chair Rep. Dina Titus (D-NV) told Marijuana Moment that her questions to the Trump administration about its move to rescind Biden-era enforcement guidance “remain unanswered”—saying it’s “a step backward for commonsense cannabis policy reform.”
Rep. Troy Carter (D-LA) and other Democratic lawmakers filed a new congressional resolution calling for equity-focused marijuana policies and urging President Donald Trump to advocate for global cannabis reform at the United Nations.
Sens. Cory Booker (D-NJ) and Rand Paul (R-KY), along with Reps. Madeleine Dean (D-PA) and Nancy Mace (R-SC), filed legislation to allow doctors to administer psychedelics and other Schedule I substances to patients with life-threatening conditions in accordance with the Right to Try law.
Rep. Warren Davidson (R-OH) asked federal financial regulators about the cannabis industry’s banking access issues during a hearing—saying that “nearly every state, whether you like it or not, has made some form of marijuana lawful in those states, and we haven’t synced up at the federal level.”
Missouri lawmakers have pre-filed several marijuana, hemp and psychedelics bills for the 2026 session—including measures to release people in prison for cannabis, allow medical marijuana use on college campuses and facilitate psilocybin therapy.
A new analysis from NORML shows that researchers published more than 37,000 scientific papers on marijuana over the past 10 years—including over 4,000 in 2025 alone, as the Trump administration continues to consider a cannabis rescheduling proposal.
The Nebraska Supreme Court heard oral arguments in a Republican former state senator’s lawsuit seeking to overturn the medical cannabis legalization law approved by voters on the ballot last year.
/ FEDERAL
The Department of Veterans Affairs posted a brief about a study indicating that CBD may harm kidneys.
The International Trade Administration approve an application for duty-free entry into the U.S. of a scientific instrument “intended to investigate the effects of the primary [cannabinoids] found in cannabis, tetrahydrocannabinol (THC) and cannabidiol (CBD) on neurodevelopment when exposure occurs during early life.”
/ STATES
The New Jersey Senate Judiciary Committee approved legislation to revise marijuana regulations, crack down on unlicensed sales and protect labor rights of cannabis industry workers.
Maine regulators issued a recall of marijuana products with unsafe levels of yeast and mold, microbials and arsenic.
Washington State regulators filed proposed changes to cannabis rules.
Colorado regulators published guidance on changes to marijuana facility and premises rules.
A Massachusetts regulator authored an op-ed about rules for social cannabis consumption businesses.
The Michigan Cannabis Regulatory Agency will meet on December 17.
—
Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.
Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.
—
/ LOCAL
The Chicago, Illinois City Council License and Consumer Protection Committee approved a proposal to ban hemp-derived THC products.
/ INTERNATIONAL
Luxembourg officials published a report on marijuana use following the enactment of legalization.
/ SCIENCE & HEALTH
A study found that “a light intensity of 600 μmol·m−2·s−1 effectively enhances both biomass and cannabinoid accumulation at the flowering stage, providing valuable insights for controlled-environment hemp cultivation aimed at maximizing CBD yield.”
A study of mice found that “a combination of CBD and THC can alleviate light aversion and pain symptoms induced by a centrally-acting migraine trigger.”
/ BUSINESS
Curaleaf is being sued for allegedly secretly allowing ad tech companies to monitor what medical cannabis patients searched, clicked and bought on its website.
/ CULTURE
Stephen Colbert joked about President Donald Trump pardoning former Honduran president Juan Orlando Hernández for drug trafficking charges.
Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox.
Photo courtesy of Chris Wallis // Side Pocket Images.
Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
